Home›Companies›Healthcare›Acuitive Technologies

Acuitive Technologies, Inc.

Makes orthopedic devices and materials for surgeons treating bone and tissue injuries.

Updated Nov 11, 2026·Latest SEC filing Sep 24, 2026·Suggest an edit

About Acuitive Technologies

Acuitive Technologies is a private company based in Allendale, New Jersey. It has reported $24,410,435 raised in four offerings on Form D since May 2021. Its chief executive is Michael McCarthy.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 14, 2026Sep 24, 2026$1,875,000of $3.0M target11$170KSimple Agreements for Future Equity (SAFEs)Rule 506(b)Form D ↗
Dec 1, 2023Dec 8, 2023$12,960,435of $18.4M target1$12.9MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 28, 2022Jun 6, 2023$5,755,000of $6.1M target17$338KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D ↗
May 10, 2021May 26, 2021amended May 25, 2022$3,820,000of $4.0M target35$109KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$24,410,435

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Acuitive Technologies's Form D filed Sep 24, 2026.

Earlier filings also listed James Maylayter (director, last listed Dec 2023) and Alex Khowaylo (executive officer and director, last listed Dec 2023).

Sources

  1. SECAcuitive Technologies, Inc. Form D, filed May 26, 2021
  2. SECAcuitive Technologies, Inc. filing history
  3. CompanyAbout Acuitive Technologies
  4. CompanyAcuitive Technologies team